Trivant Custom Portfolio Group LLC Buys 1,043 Shares of Zoetis Inc. (NYSE:ZTS)

Trivant Custom Portfolio Group LLC grew its stake in Zoetis Inc. (NYSE:ZTS) by 16.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 7,310 shares of the company’s stock after purchasing an additional 1,043 shares during the period. Trivant Custom Portfolio Group LLC’s holdings in Zoetis were worth $1,204,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in Zoetis by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 41,366,877 shares of the company’s stock worth $6,739,905,000 after buying an additional 120,158 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Zoetis by 1.8% in the fourth quarter. Geode Capital Management LLC now owns 10,617,897 shares of the company’s stock valued at $1,726,075,000 after acquiring an additional 190,137 shares during the period. Polen Capital Management LLC lifted its holdings in shares of Zoetis by 17.5% in the 4th quarter. Polen Capital Management LLC now owns 7,483,194 shares of the company’s stock worth $1,219,237,000 after acquiring an additional 1,116,541 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Zoetis by 78.5% during the 4th quarter. Wellington Management Group LLP now owns 6,958,543 shares of the company’s stock worth $1,133,755,000 after purchasing an additional 3,059,255 shares during the period. Finally, Northern Trust Corp grew its holdings in Zoetis by 13.3% during the 4th quarter. Northern Trust Corp now owns 6,426,394 shares of the company’s stock valued at $1,047,052,000 after purchasing an additional 755,893 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

ZTS has been the subject of several analyst reports. Piper Sandler raised their price objective on shares of Zoetis from $205.00 to $210.00 and gave the stock an “overweight” rating in a research note on Monday, May 12th. UBS Group decreased their price target on Zoetis from $189.00 to $170.00 and set a “neutral” rating for the company in a research note on Wednesday, May 7th. Stifel Nicolaus cut Zoetis from a “buy” rating to a “hold” rating and dropped their price objective for the company from $165.00 to $160.00 in a report on Wednesday. Finally, Wall Street Zen upgraded Zoetis from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Two investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $212.13.

Zoetis Stock Down 4.0%

Shares of NYSE ZTS opened at $155.21 on Thursday. Zoetis Inc. has a 52-week low of $139.70 and a 52-week high of $200.33. The firm has a market capitalization of $69.10 billion, a price-to-earnings ratio of 27.87, a PEG ratio of 2.68 and a beta of 0.94. The stock has a 50 day moving average price of $159.26 and a 200 day moving average price of $163.68. The company has a debt-to-equity ratio of 1.12, a quick ratio of 1.04 and a current ratio of 1.74.

Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The business had revenue of $2.22 billion during the quarter, compared to analyst estimates of $2.20 billion. During the same period in the previous year, the company posted $1.38 EPS. Zoetis’s revenue was up 1.4% on a year-over-year basis. Sell-side analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 3rd. Investors of record on Friday, July 18th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date of this dividend is Friday, July 18th. Zoetis’s dividend payout ratio (DPR) is presently 35.91%.

Insiders Place Their Bets

In other news, EVP Roxanne Lagano sold 652 shares of the business’s stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $170.00, for a total value of $110,840.00. Following the completion of the sale, the executive vice president now owns 15,129 shares in the company, valued at approximately $2,571,930. The trade was a 4.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.18% of the stock is owned by company insiders.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.